by Marco Torres
December 15, 2011
from PreventDisease Website
They are about to make publicly
available data on the genetic blueprint of medicinal plants so that
their beneficial properties and genes are identified for drug
Project partner Dr Sarah O'Connor at the John Innes Centre will now work with her research group towards the first full genetic sequence of a medicinal plant and will also experiment with genetically modifying properties from different plants to create the first new-to-nature compounds derived from plants.
A priority focus will be compounds which could be used to develop anticancer drugs.
Some well-known medicines that fail a large percentage of their users come from plants.
The reason they fail is because the chemical structure of the substances are forever changed and the body treats the new substance as foreign, essentially damaging Mother Nature's delicate balance. For example the once ubiquitous foxglove gives us the cardiac muscle stimulant digoxin.
However, ingested digoxin can cause heart block, rapid heartbeat, slow heart rate and disturbances in heart rhythm. The periwinkle plant offers a source for the widely used chemotherapy drugs vincristine and vinblastine. Both drugs cause peripheral neuropathy, hair loss, paresthesia, constipation and low blood counts.
These examples serve as only a few of thousands of drugs that are manipulated and denatured which severely and negatively affects their interaction with human physiology.
The biggest difference is that the interactions of natural compounds generally react naturally and within tolerances of the body's assimilation.
manufactured drugs do not. That's why approved pharmaceutical
medications are one of the biggest killers in developed nations.
Over the 30 years, there have been zero deaths from natural health products, yet there have been well over 3 million deaths related to prescription drug use.
In most developed countries,
pharmaceutical drug deaths far exceed traffic fatalities. In the U.S,
drugs exceeded the amount of traffic-related deaths, killing at
least 37,485 people nationwide in the United States.
Since biotechnology plants as a category
are supposed to be substantially equivalent to their non-genetically
engineered counterparts, the endgame for all of this is no
regulation at all.
The millions of those who have died on these medications can serve as a testament to the failure of this approach. Genetically modifying any part of nature is flawed in its intention from the get go.
Couple that with a greedy corporate
mindset which only has one goal - profit, and you have a wreckless,
careless and mindless recipe for disaster.